Search Results - "De Rosa SC"

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.

Authors: Korber, Bette Seaman, Michael S. Mkhize, Nonhlanhla N. et al.

Source: PLoS Pathogens. 4/23/2026, Vol. 22 Issue 4, p1-22. 22p.

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.

Authors: De Rosa SC Gravett RM Hahn WO et al.

Corporate Authors: De Rosa SC Gravett RM Hahn WO et al.

Source: Vaccine [Vaccine] 2026 Apr 19; Vol. 79, pp. 128487. Date of Electronic Publication: 2026 Mar 21.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.

Authors: Whitaker JA Rebolledo PA Abate G et al.

Corporate Authors: Whitaker JA Rebolledo PA Abate G et al.

Source: Vaccine [Vaccine] 2026 Apr 02; Vol. 77, pp. 128358. Date of Electronic Publication: 2026 Feb 25.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Candidate correlates of protection in the HVTN505 HIV-1 vaccine efficacy trial identified by positive-unlabeled learning.

Authors: Xu, Shiwei Hudson, Aaron Janes, Holly E. et al.

Source: PLoS Computational Biology. 11/26/2025, Vol. 21 Issue 11, p1-19. 19p.

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

Authors: Kobie JJ Williams WB Hahn WO et al.

Corporate Authors: Kobie JJ Williams WB Hahn WO et al.

Source: MedRxiv : the preprint server for health sciences [medRxiv] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial.

Authors: Voillet V van Duijn J Vanshylla K et al.

Source: EBioMedicine [EBioMedicine] 2025 Dec; Vol. 122, pp. 106017. Date of Electronic Publication: 2025 Nov 13.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age.

Authors: Rostad CA Campbell JD Paulsen GC et al.

Source: The Journal of infectious diseases [J Infect Dis] 2025 Jun 02; Vol. 231 (5), pp. e945-e955.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.

Authors: Girard B Figueroa AL De Rosa SC et al.

Source: Frontiers in immunology [Front Immunol] 2025 Apr 03; Vol. 16, pp. 1505871. Date of Electronic Publication: 2025 Apr 03 (Print Publication: 2025).

Publication Type: Clinical Trial, Phase III; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses.

Authors: Mosmann TR Rebhahn JA De Rosa SC et al.

Source: Frontiers in immunology [Front Immunol] 2024 Jun 06; Vol. 15, pp. 1347926. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.

Authors: Schuster DJ Li SS Mielke D et al.

Source: IScience [iScience] 2026 Mar 09; Vol. 29 (4), pp. 115277. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity.

Authors: Paila YD Pajon R Banbury B et al.

Source: NPJ vaccines [NPJ Vaccines] 2026 Feb 19; Vol. 11 (1). Date of Electronic Publication: 2026 Feb 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE

CD24-Fc resolves inflammation and enhances anti-HIV CD8 T cells with polyfunctionality during HIV-1 infection under ART.

Authors: Li, Guangming Ma, Jianping Yu, Haisheng et al.

Source: PLoS Pathogens. 8/8/2025, Vol. 21 Issue 8, p1-18. 18p.

ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

Authors: Fisher LH Lazarus E Yu C et al.

Corporate Authors: Fisher LH Lazarus E Yu C et al.

Source: PLOS global public health [PLOS Glob Public Health] 2025 Apr 11; Vol. 5 (4), pp. e0004250. Date of Electronic Publication: 2025 Apr 11 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.

Authors: Stieh DJ Barouch DH Comeaux C et al.

Corporate Authors: Stieh DJ Barouch DH Comeaux C et al.

Source: The Journal of infectious diseases [J Infect Dis] 2023 Apr 18; Vol. 227 (8), pp. 939-950.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.

Authors: McGuire DJ Akondy RS Yang S et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2025 Aug 12; Vol. 122 (32), pp. e2322982122. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

A trimer ancestral spike-based mRNA vaccine confers cross-generational protection against SADS-CoV.

Authors: Zhang, Teng Yao, Jiale Guo, Xinchun et al.

Source: Journal of Nanobiotechnology. 11/4/2025, Vol. 23 Issue 1, p1-14. 14p.

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

Authors: Anywaine Z Barry H Anzala O et al.

Corporate Authors: Anywaine Z Barry H Anzala O et al.

Source: PLoS medicine [PLoS Med] 2022 Jan 11; Vol. 19 (1), pp. e1003865. Date of Electronic Publication: 2022 Jan 11 (Print Publication: 2022).

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.

Authors: Ober Shepherd BL Scott PT Hutter JN et al.

Corporate Authors: Ober Shepherd BL Scott PT Hutter JN et al.

Source: The Lancet. Microbe [Lancet Microbe] 2024 Jun; Vol. 5 (6), pp. e581-e593. Date of Electronic Publication: 2024 May 15.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

HIV-1 controllers possess a unique CD8⁺ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers.

Authors: Jones, Amber D. Capriotti, Zachary Santos, Erin et al.

Source: PLoS ONE. 8/28/2025, Vol. 20 Issue 8, p1-24. 24p.

Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge.

Authors: Oyong DA Duffy FJ Neal ML et al.

Source: PLoS pathogens [PLoS Pathog] 2023 May 17; Vol. 19 (5), pp. e1011051. Date of Electronic Publication: 2023 May 17 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE